Single-dose intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of post-operative anaemia in colorectal cancer patients: a randomised controlled trial.

MLA

Laso-Morales, María J., et al. “Single-Dose Intravenous Ferric Carboxymaltose Infusion versus Multiple Fractionated Doses of Intravenous Iron Sucrose in the Treatment of Post-Operative Anaemia in Colorectal Cancer Patients: A Randomised Controlled Trial.” Blood Transfusion (17232007), vol. 20, no. 4, July 2022, pp. 310–18. EBSCOhost, https://doi.org/10.2450/2021.0157-21.

APA

Laso-Morales, M. J., Vives, R., Bisbe, E., García-Erce, J. A., Muñoz, M., Martínez-López, F., Carol-Boeris, F., & Pontes-García, C. (2022). Single-dose intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of post-operative anaemia in colorectal cancer patients: a randomised controlled trial. Blood Transfusion (17232007), 20(4), 310–318. https://doi.org/10.2450/2021.0157-21

Chicago

Laso-Morales, María J., Roser Vives, Elvira Bisbe, José A. García-Erce, Manuel Muñoz, Fernando Martínez-López, Federico Carol-Boeris, and Caridad Pontes-García. 2022. “Single-Dose Intravenous Ferric Carboxymaltose Infusion versus Multiple Fractionated Doses of Intravenous Iron Sucrose in the Treatment of Post-Operative Anaemia in Colorectal Cancer Patients: A Randomised Controlled Trial.” Blood Transfusion (17232007) 20 (4): 310–18. doi:10.2450/2021.0157-21.